Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Colitis-associated cancer
~
Kusunoki, Masato.
Colitis-associated cancer
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Colitis-associated cancer/ edited by Masato Kusunoki.
other author:
Kusunoki, Masato.
Published:
Tokyo :Springer Japan : : 2016.,
Description:
viii, 150 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
Subject:
Inflammatory bowel diseases. -
Online resource:
http://dx.doi.org/10.1007/978-4-431-55522-3
ISBN:
9784431555223
Colitis-associated cancer
Colitis-associated cancer
[electronic resource] /edited by Masato Kusunoki. - Tokyo :Springer Japan :2016. - viii, 150 p. :ill., digital ;24 cm.
Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
ISBN: 9784431555223
Standard No.: 10.1007/978-4-431-55522-3doiSubjects--Topical Terms:
676264
Inflammatory bowel diseases.
LC Class. No.: RC280.C6
Dewey Class. No.: 616.994347
Colitis-associated cancer
LDR
:02500nam a2200313 a 4500
001
861108
003
DE-He213
005
20160727151304.0
006
m d
007
cr nn 008maaau
008
170720s2016 ja s 0 eng d
020
$a
9784431555223
$q
(electronic bk.)
020
$a
9784431555216
$q
(paper)
024
7
$a
10.1007/978-4-431-55522-3
$2
doi
035
$a
978-4-431-55522-3
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.C6
072
7
$a
MN
$2
bicssc
072
7
$a
MED085000
$2
bisacsh
082
0 4
$a
616.994347
$2
23
090
$a
RC280.C6
$b
C696 2016
245
0 0
$a
Colitis-associated cancer
$h
[electronic resource] /
$c
edited by Masato Kusunoki.
260
$a
Tokyo :
$c
2016.
$b
Springer Japan :
$b
Imprint: Springer,
300
$a
viii, 150 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Chapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
520
$a
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
650
0
$a
Inflammatory bowel diseases.
$3
676264
650
0
$a
Ulcerative colitis.
$3
1103254
650
0
$a
Crohn's disease.
$3
1064554
650
0
$a
Rectum
$x
Cancer.
$3
674351
650
0
$a
Colon (Anatomy)
$x
Cancer.
$3
768420
650
1 4
$a
Medicine & Public Health.
$3
593949
650
2 4
$a
Surgery.
$3
644132
650
2 4
$a
Surgical Oncology.
$3
673742
650
2 4
$a
Cancer Research.
$3
668358
650
2 4
$a
Gene Function.
$3
782134
700
1
$a
Kusunoki, Masato.
$3
1103253
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-4-431-55522-3
950
$a
Medicine (Springer-11650)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login